Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

Clinical trial NCT00006400 · COMPLETED

Trial details

NCT number: NCT00006400
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hematologic Diseases Anemia, Sickle Cell

Start date: 2000-08-01
Primary completion: 2009-09-01
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.